$165-185k
+ Equity
More information about location
Obesity and metabolic health treatment
Job no longer available
Obesity and metabolic health treatment
201-500 employees
Job no longer available
$165-185k
+ Equity
More information about location
201-500 employees
Calibrate's mission is to change the way the world treats weight.
Obesity affects four in ten Americans, but access to effective treatment has historically been barred by its categorisation as a lifestyle problem as opposed to a healthcare issue. Calibrate delivers obesity treatment programs that combine physiological training with cutting-edge medication, to combat unhealthy lifestyle habits and provide weight loss that lasts.
The types of medication supplied by Calibrate have been proven to deliver positive weight loss results across several trials. When combined with sustainable physiological change, like with Calibrate, clinically-reviewed results have demonstrated that patients are able to both meet and sustain their weight-loss goals – an impressive feat considering that 95% of traditional diets fail.
It is worth noting that weight-loss medications like those supplied by Calibrate, though displaying positive results thus far, have not undergone the extensive trialling required to confidently state they are safe and effective for long-term use - which does present issues as once on them, patients must continue to take the drugs to avoid regaining the lost weight.
That said, with Calibrate boasting over 20,000 people helped, and patients sustaining health outcomes beyond their first year, its programs are certainly effective, and it remains one to watch as the space evolves. The company has seen good funding in the past, and benefited from the wider buzz around next-gen weight-loss drugs, though it has also seen some negative press surrounding a round of layoffs that was announced over zoom.
Steph
Company Specialist at Welcome to the Jungle
Few candidates hear
back within 2 weeks
-23% employee growth in 12 months
Nov 2023
$29m
GROWTH EQUITY VC
Aug 2021
$100m
SERIES B
Union Square, New York, NY
Isabelle Kenyon
(CEO)Entrepreneur, Founder & CEO with a background in leading beloved consumer brands, scaling early-stage, high-growth start-ups, and investment banking.
Share this job
View 5 more jobs at Calibrate